GLO HEALTHCARE
LIVE

Serial Number

97837490

Owner

GLO New TopCo SCA

Attorney

Dermot J. Horgan

Filing Date

Mar 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GLO HEALTHCARE Trademark

Serial Number: 97837490 • Registration: 7773243

GLO HEALTHCARE is a trademark filed by GLO New TopCo SCA on March 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GLO New TopCo SCA

13, rue Aldringen
Luxembourg 1118 , LU

Entity Type: 99

Trademark Details

Filing Date

March 14, 2023

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Pharmaceutical preparations for human use in diagnosis and therapy of diseases in the fields of oncology, renal disease, cardiology, lung disease, bone disease and neuroscience; Radiopharmaceutical preparations for use in diagnostic imaging, for use in therapeutic treatments, namely the destruction of diseased tissue, and for use in the treatments of non-cancerous conditions, namely the treatment of blood disorders, and for reducing the function of overactive thyroid glands; Pharmaceutical kits for making radiopharmaceutical preparations for nuclear medical use, namely kits comprising diagnostic radioisotopes and therapeutic radioisotopes, and also containing chelating chemical agents, reducing chemical agents, buffers, ligands and targeting molecules, chemical solvents, chemical stabilizers and preservatives, isotope exchange and radiolabeling reagents, radionuclide generators, sterilizing agents, and printed and downloadable instruction manuals for synthesis, all sold as a unit

Medical generators specially adapted for medical purposes, namely for use in the production and transportation of nuclear medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for medical use for administering radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor; Elution shields for medical use, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from Mo99/Tc99m generators and radiation shielding

Pharmaceutical research and development services; providing medical research and scientific research information in the field of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
EXPARTE APPEAL TERMINATED
Feb 14, 2025 EXPT
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 4, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 4, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 4, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 4, 2025 CNEA
EX PARTE APPEAL-INSTITUTED
Jan 14, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 14, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 14, 2025 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 16, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 17, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 17, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 17, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2024 CRFA
ASSIGNED TO LIE
Sep 3, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 26, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 26, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2023 NWOS
NEW APPLICATION ENTERED
Mar 17, 2023 NWAP